Agilent breaks ground on manufacturing expansion in Colorado
Agilent Technologies is making a $725m investment to double manufacturing capacity of therapeutic nucleic acids in Frederick, Colorado.
Archives for February 20, 2023
Celanese partners with Johns Hopkins on eye drug delivery
The partners will collaborate on a study of sustained drug delivery to the suprachoroidal space in the eye.
Similis Bio and Novel351k partner on biosimilars for cancer and autoimmune diseases
Similis Bio and Novel351k will co-develop three biosimilar programs targeting cancer and autoimmune diseases.
Moderna announces mixed results for influenza mRNA vaccine candidate
Phase 3 interim data showed the mRNA vaccine candidate generated a strong immune response against Influenza A; but failed to demonstrate it was at least as effective as an existing vaccine against Influenza B.
EMA gave the green light to 89 medicines in 2022; including more ATMPs
In 2022, the European Medicines Agency (EMA) recommended 89 medicines for marketing authorization: including six advanced therapy medicinal products and eight biosimilars.